Donald Trump's appointment of Robert F Kennedy Junior as health czar means interesting times for US-focused ASX life sciences plays.
The ASX IPO market is picking up after a quiet 2024 with major listings ahead, including Symal, Fulcrum and Cuscal.
It's unlikely a surprise to anyone that over the past few years, the biggest-moving sector represented on The List – Australia's Richest 250 – is tech.
Sun Silver assays highlight growth potential beyond its current 195.7Mt resource at Maverick Springs.
Brazilian Critical Minerals assays return strong magnet rare earths results at Ema project.
